These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 20440292)

  • 21. Biomarkers for the prediction of type 2 diabetes and cardiovascular disease.
    Herder C; Karakas M; Koenig W
    Clin Pharmacol Ther; 2011 Jul; 90(1):52-66. PubMed ID: 21654741
    [TBL] [Abstract][Full Text] [Related]  

  • 22. From genome-wide association studies to functional genomics: new insights into cardiovascular disease.
    McPherson R
    Can J Cardiol; 2013 Jan; 29(1):23-9. PubMed ID: 23200092
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Biomarkers in cardiovascular diseases: how can the "-omics" revolution be applicable at the bedside. Introduction.
    Tang WH
    Prog Cardiovasc Dis; 2012; 55(1):1-2. PubMed ID: 22824104
    [No Abstract]   [Full Text] [Related]  

  • 24. [Polygenic risk prediction of common diseases: from epidemiology to clinical application].
    Jansen PR; Broeders MJM; Cornel MC; Meijers-Heijboer H
    Ned Tijdschr Geneeskd; 2019 Sep; 163():. PubMed ID: 31556493
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Framingham Heart Study 100K project: genome-wide associations for cardiovascular disease outcomes.
    Larson MG; Atwood LD; Benjamin EJ; Cupples LA; D'Agostino RB; Fox CS; Govindaraju DR; Guo CY; Heard-Costa NL; Hwang SJ; Murabito JM; Newton-Cheh C; O'Donnell CJ; Seshadri S; Vasan RS; Wang TJ; Wolf PA; Levy D
    BMC Med Genet; 2007 Sep; 8 Suppl 1(Suppl 1):S5. PubMed ID: 17903304
    [TBL] [Abstract][Full Text] [Related]  

  • 26. From circulating biomarkers to genomics and imaging in the prediction of cardiovascular events in the general population.
    Fava C; Montagnana M; Guidi GC; Melander O
    Ann Med; 2012 Aug; 44(5):433-47. PubMed ID: 21623699
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cardiac Troponin T and Troponin I in the General Population.
    Welsh P; Preiss D; Hayward C; Shah ASV; McAllister D; Briggs A; Boachie C; McConnachie A; Padmanabhan S; Welsh C; Woodward M; Campbell A; Porteous D; Mills NL; Sattar N
    Circulation; 2019 Jun; 139(24):2754-2764. PubMed ID: 31014085
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genomic risk prediction of complex human disease and its clinical application.
    Abraham G; Inouye M
    Curr Opin Genet Dev; 2015 Aug; 33():10-6. PubMed ID: 26210231
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genetic Architecture of the Cardiovascular Risk Proteome.
    Benson MD; Yang Q; Ngo D; Zhu Y; Shen D; Farrell LA; Sinha S; Keyes MJ; Vasan RS; Larson MG; Smith JG; Wang TJ; Gerszten RE
    Circulation; 2018 Mar; 137(11):1158-1172. PubMed ID: 29258991
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genomics and the prospects of existing and emerging therapeutics for cardiovascular diseases.
    Zaiou M; Benachour H; Marteau JB; Visvikis-Siest S; Siest G
    Curr Pharm Des; 2009; 15(27):3193-206. PubMed ID: 19754391
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genetic markers: progress and potential for cardiovascular disease.
    Gibbons GH; Liew CC; Goodarzi MO; Rotter JI; Hsueh WA; Siragy HM; Pratt R; Dzau VJ
    Circulation; 2004 Jun; 109(25 Suppl 1):IV47-58. PubMed ID: 15226250
    [No Abstract]   [Full Text] [Related]  

  • 32. Evaluating the relationship between alcohol consumption, tobacco use, and cardiovascular disease: A multivariable Mendelian randomization study.
    Rosoff DB; Davey Smith G; Mehta N; Clarke TK; Lohoff FW
    PLoS Med; 2020 Dec; 17(12):e1003410. PubMed ID: 33275596
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Approaching biomarker discovery through genomics.
    Rich SS
    J Cardiovasc Transl Res; 2008 Mar; 1(1):21-4. PubMed ID: 20559954
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genomics of Cardiovascular Measures of Autonomic Tone.
    Sigurdsson MI; Waldron NH; Bortsov AV; Smith SB; Maixner W
    J Cardiovasc Pharmacol; 2018 Mar; 71(3):180-191. PubMed ID: 29300220
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Recent developments in cardiovascular genetics.
    Editors
    Circ Res; 2013 Oct; 113(9):e88-91. PubMed ID: 24115069
    [No Abstract]   [Full Text] [Related]  

  • 36. Precision phenotyping, panomics, and system-level bioinformatics to delineate complex biologies of atherosclerosis: rationale and design of the "Genetic Loci and the Burden of Atherosclerotic Lesions" study.
    Voros S; Maurovich-Horvat P; Marvasty IB; Bansal AT; Barnes MR; Vazquez G; Murray SS; Voros V; Merkely B; Brown BO; Warnick GR
    J Cardiovasc Comput Tomogr; 2014; 8(6):442-51. PubMed ID: 25439791
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Randomized trial of personal genomics for preventive cardiology: design and challenges.
    Knowles JW; Assimes TL; Kiernan M; Pavlovic A; Goldstein BA; Yank V; McConnell MV; Absher D; Bustamante C; Ashley EA; Ioannidis JP
    Circ Cardiovasc Genet; 2012 Jun; 5(3):368-76. PubMed ID: 22715281
    [No Abstract]   [Full Text] [Related]  

  • 38. Human In Vitro Models for Assessing the Genomic Basis of Chemotherapy-Induced Cardiovascular Toxicity.
    Pinheiro EA; Magdy T; Burridge PW
    J Cardiovasc Transl Res; 2020 Jun; 13(3):377-389. PubMed ID: 32078739
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pro-inflammatory genetic markers of atherosclerosis.
    Incalcaterra E; Accardi G; Balistreri CR; Caimi G; Candore G; Caruso M; Caruso C
    Curr Atheroscler Rep; 2013 Jun; 15(6):329. PubMed ID: 23591672
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular markers for cardiovascular disease: cardiovascular biomarkers to proteomic discovery.
    Suzuki T; Nagai R
    Nat Clin Pract Cardiovasc Med; 2008 Jun; 5(6):295. PubMed ID: 18506210
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.